Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36a-like (RPL36AL) is a structural protein component of the large 60S subunit of cytoplasmic ribosomes, the organelles responsible for protein synthesis[4][5][7]. The protein is highly similar in sequence to yeast ribosomal protein L44 and belongs to the L44E (L36AE) family of ribosomal proteins[4][5]. RPL36AL is encoded by a protein-coding gene that lacks introns in its coding regions, which likely resulted from retrotransposition of its X-linked homolog[2][10]. RPL36AL and its close paralog, RPL36A, encode nearly identical proteins but are distinct genes[5][7]. RPL36AL is ubiquitously expressed and is important for the functioning of the ribosome[2]. While mutations or dysfunction in ribosomal proteins may be implicated in some diseases through disruption of protein synthesis (notably Diamond-Blackfan anemia and rare cancer associations), RPL36AL itself is not currently considered a direct drug target or therapeutic receptor/enzyme/transporter[7]. There is no evidence of direct safety concerns, mechanism-based drug interactions, or biomarker utility related to this protein. RPL36AL is mainly relevant as a basic ribosomal protein contributing to core cell biology rather than as a regulatory target or therapeutic intervention point.
Not applicable; there are currently no drugs known to target this protein specifically[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a-like (RPL36AL).